Skip to content
Strength & muscleResearch article3 min read

Home exercise and breathing training: farther walking, less fatigue in heart failure

MoveVitals Editorial Collective · Study published · Reading updated

Original paper:Beyond the clinic: a six-month home-based exercise and respiratory rehabilitation program improves functional capacity, respiratory muscle strength, and fatigue in chronic heart failure. · Frontiers in rehabilitation sciences · 2026 · Original paper ↗

Key takeaway

In 28 people with stable heart failure who completed a 6-month home program of exercise and respiratory muscle training, 6-minute walk distance rose by 37.86 m (p = 0.001) and fatigue fell by 0.68 points (p = 0.029). There was no control group at 6 months, so the gains cannot be separated from natural change or the effect of being monitored.

Study design

Research article

Reading basis

Published abstract

Reading focus

Design & applicability

The research question

The best way to deliver rehabilitation to people with heart failure is still being worked out, and clinic-based programs are hard for many to attend. The authors wanted to know whether a 6-month home-based program was safe and whether it improved exercise capacity, breathing-muscle strength and quality of life.

Who and how

Randomized trial (ClinicalTrials.gov NCT03780803) in patients with stable heart failure: 63 were randomized, and 28 from the intervention group completed the study and were analyzed. Measures at baseline and 6 months were the 6-minute walk test, respiratory muscle strength, and quality of life (SF-36 and the Fatigue Severity Scale, FSS). Adverse events and adherence were monitored. Because of the COVID-19 pandemic the study departed from its protocol, and the control group was not assessed at 6 months.

What it found

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    Walking distance in 6 minutes increased by 37.86 meters (p = 0.001).
  2. 2
    Respiratory muscle strength rose: maximal inspiratory pressure (PImax) by 20.21 cmH2O and maximal expiratory pressure (PEmax) by 20.75 cmH2O (both p < 0.01).
  3. 3
    Fatigue on the FSS fell by a mean of 0.68 points (p = 0.029). SF-36 results are not reported in the abstract.
  4. 4
    Adherence to the exercise protocol averaged 91.5 ± 15.3%, and no serious adverse events were reported.

Limits & uncertainty

  1. 1
    The control group was not assessed at 6 months, so this is effectively a before-and-after comparison in one group.
  2. 2
    Only 28 patients were analyzed, from 63 randomized; people who finish a home program are likely to be the more motivated ones.
  3. 3
    The study changed from its original protocol because of COVID-19, which the authors acknowledge.
  4. 4
    The abstract's claim that the program is 'safe and effective' rests on this uncontrolled comparison; this reading is based on the abstract only.

What to take from it

For people with stable heart failure, a structured home program that includes breathing-muscle training looks feasible and safe in this small group, and adherence was high. It does not prove the program works better than usual care. Anyone with heart failure should have exercise advice set by their own care team.

Reading your own data

Step counts, walking tests done the same way each time, and a simple weekly fatigue rating could mirror the outcomes tracked here. Compare your own results under the same conditions (same route, same time of day) and look at trends over months rather than single days.

How to read this evidence

The index does not establish a precise design. Read the methods before making causal claims; check population, comparator, outcomes and uncertainty in the source.

Authors’ structured abstract English

The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.

Introduction

Optimal models of rehabilitation dedicated for patients with heart failure (HF) remain under investigation. The aim of this study was to assess the safety and effectiveness of a 6-month home-based rehabilitation program in patients with HF.

Materials and methods

63 patients with stable HF were randomized, 28 patients from intervention group completed the study and were included in the analysis. Assessments including the 6-minute walk test, respiratory muscle strength, and quality of life measures (SF-36 and Fatigue Severity Scale - FSS) were conducted at baseline and after 6 months. Additionally, adverse events and adherence to the training protocol were monitored.

Results

Due to objective challenges caused by the COVID-19 pandemic outbreak, the course and final outcomes of the study differed from the original protocol; the control group was not assessed after 6 months. In the intervention group, 6 months of rehabilitation resulted in statistically significant improvements: the 6-minute walk distance increased by 37.86 meters ( p = 0.001), maximal inspiratory pressure (PImax) improved by 20.21 cmH₂O, and maximal expiratory pressure (PEmax) by 20.75 cmH₂O (both p < 0.01). A significant reduction in fatigue was observed, as measured by FSS, with a mean decrease of 0.68 points ( p = 0.029). Adherence to the exercise protocol averaged 91.5 ± 15.3%. No serious adverse events were reported.

Conclusions

The home-based rehabilitation program, including respiratory muscle training, is safe and effective for patients with chronic HF. It improves functional capacity and reduces fatigue levels.

Clinical trial registration

https://clinicaltrials.gov/ct2/show/NCT03780803, ClinicalTrials.gov, NCT03780803. Registered 19/12/2018.

Sources & attribution

Beyond the clinic: a six-month home-based exercise and respiratory rehabilitation program improves functional capacity, respiratory muscle strength, and fatigue in chronic heart failure.

Ciołkiewicz M, Wojciuk M, Kuryliszyn-Moskal A, Dakowicz A, Sawicka-Śmiarowska E, Kamiński K.

Frontiers in rehabilitation sciences · 2026-10-14

DOI: 10.3389/fresc.2026.1958027 ↗PubMed · 42952845 ↗Europe PMC · Recorded licence: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

MoveVitals editorial interpretation · educational content · no individual clinical review recorded

Sources checked 2026-11-01

Practical guides

Read in context

·Overview of reviews

ACSM review of 137 reviews: resistance training works, and few programme details matter

The American College of Sports Medicine pooled 137 systematic reviews (over 30,000 healthy adults) and concluded that resistance training beats no exercise for strength, muscle size, power, endurance and several function tests. Few programme details changed results consistently: heavier loads (80% or more of one-repetition maximum) and 2 to 3 sets favoured strength, and at least 10 sets a week favoured muscle size, while training to failure, exercise type and periodization did not. It summarises reviews rather than new trials, gives no pooled effect sizes, and drew mostly on untrained adults and overlapping source trials.

Medicine & Science in Sports & Exercise

In-depth explainersRead study →
·Trial meta-analysis

Nearly every resistance training plan beat no exercise; heavy loads led for strength

In a network meta-analysis of randomised trials in healthy adults (178 studies and 5097 people for strength, 119 studies and 3364 people for muscle size), nearly all resistance training prescriptions beat no exercise. Higher-load, multiset, thrice-weekly training ranked best for strength (standardised mean difference 1.60, 95% credible interval 1.38 to 1.82) and higher-load, multiset, twice-weekly training for muscle size (0.66, 0.47 to 0.85). Most prescriptions could not be statistically separated from each other (the 95% interval contained zero in 91% of the comparisons between them) and risk of bias was moderate to high, so the rankings are tentative.

British Journal of Sports Medicine

In-depth explainersRead study →
·Observational meta-analysis

Muscle-strengthening linked to lower risk of death, heart disease, cancer and diabetes

Pooling 16 prospective cohort studies of adults, people who did muscle-strengthening activity had a 15% lower risk of all-cause mortality (RR 0.85, 95% CI 0.79 to 0.93) and a 17% lower risk of both cardiovascular disease and diabetes (RR 0.83 for each) than people who did none. The pooled mortality curve was lowest at about 40 min/week (RR 0.83), but whether larger amounts help or hurt is unclear. All of this is observational, from mostly US self-reported data, and the authors rated the certainty of evidence as very low for most outcomes.

British Journal of Sports Medicine

In-depth explainersRead study →
·Trial meta-analysis

Protein supplements and weight training: small extra gains, smaller in older adults

Pooling 49 randomised trials with 1,863 healthy adults who did resistance training for at least 6 weeks, protein supplements added 0.30 kg of fat-free mass (95% CI 0.09 to 0.52) and 2.49 kg of one-repetition-maximum strength (0.64 to 4.33) on top of training alone. These gains were small next to the effect of training itself, were weaker with older age, and the suggested plateau near 1.6 g/kg/day was not statistically significant (p=0.079). One author has received funding from the US National Dairy Council, which supported trials in the analysis.

British Journal of Sports Medicine

In-depth explainersRead study →
Strength & muscle →